+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fiducial Markers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
Fiducial Markers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030- Product Image
New

Fiducial Markers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 187 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5950250
Free Webex Call
10% Free customization
Description Jump to:

Metal Based Markers is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Fiducial Markers Market, valued at USD 97.38 Million in 2024, is projected to experience a CAGR of 5.30% to reach USD 132.75 Million by 2030. Fiducial markers are small, implantable objects utilized in medical imaging to establish precise reference points for guiding radiation therapy and surgical procedures, thereby enabling accurate tumor localization and minimizing collateral damage to healthy tissue. The global market for these markers is primarily propelled by the increasing worldwide incidence of cancer, the expanding adoption of advanced imaging modalities like MRI and CBCT, and continuous technological advancements in precision radiotherapy techniques.

Key Market Drivers

The rising global incidence of cancer significantly propels demand for fiducial markers by expanding the patient population requiring precise radiation therapy. Growing cancer prevalence necessitates accurate tumor localization, particularly in sensitive anatomical regions. Fiducial markers are essential for precision in modern oncology, enhancing therapeutic efficacy and minimizing collateral damage. According to the American Cancer Society, in April 2024, lung cancer was the most frequently diagnosed cancer in 2022, with approximately 2.5 million new cases globally, highlighting a substantial disease burden often necessitating targeted radiation treatment. This prevalence drives continuous demand for accurate therapeutic guidance.

Key Market Challenges

The significant cost associated with fiducial marker implantation procedures presents a considerable impediment to the growth of the Global Fiducial Markers Market. These expenses, encompassing the markers, surgical expertise, specialized equipment, and necessary follow-up imaging for precise placement, restrict widespread adoption. This high expenditure is particularly challenging within healthcare systems facing budget constraints or limited reimbursement policies, directly impacting market penetration and resulting in lower utilization rates despite the acknowledged benefits of improved treatment accuracy and reduced collateral damage.

Key Market Trends

Biodegradable marker development addresses patient comfort and reduces the need for secondary removal procedures, thereby enhancing patient outcomes and potentially reducing healthcare costs. This innovation aligns with the broader medical shift toward sustainable and patient-friendly solutions. The American Medical Association, at its 2023 Interim Meeting, referred Resolution 2-I-23 concerning single-use/disposable medical devices, acknowledging the need to address adverse environmental consequences and balance fiscal expense with patient safety concerns, which reflects the growing recognition of biodegradable material benefits.

Key Market Players Profiled:

  • CIVCO Radiotherapy
  • IZI Medical Products
  • Boston Scientific Corporation
  • Naslund Medical AB
  • Best Medical International, Inc.
  • Nanovi A/S
  • Carbon Medical Technologies Inc.
  • Eckert & Ziegler
  • Innovative Oncology Solutions
  • Medtronic plc

Report Scope:

In this report, the Global Fiducial Markers Market has been segmented into the following categories:

By Product:

  • Metal-based Markers
  • Polymer-based Markers
  • Other Fiducial Markers

By Modality:

  • CT/CBCT
  • MRI
  • Ultrasound
  • Radiotherapy

By Cancer Type:

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Gastric Cancer
  • Other Cancers

By End user:

  • Hospitals & Clinics
  • Independent Radiotherapy Centers
  • Cancer Research Centers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fiducial Markers Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Fiducial Markers Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Metal-based Markers, Polymer-based Markers, Other Fiducial Markers)
5.2.2. By Modality (CT/CBCT, MRI, Ultrasound, Radiotherapy)
5.2.3. By Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Other Cancers)
5.2.4. By End user (Hospitals & Clinics, Independent Radiotherapy Centers, Cancer Research Centers)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Fiducial Markers Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Modality
6.2.3. By Cancer Type
6.2.4. By End user
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Fiducial Markers Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Modality
6.3.1.2.3. By Cancer Type
6.3.1.2.4. By End user
6.3.2. Canada Fiducial Markers Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Modality
6.3.2.2.3. By Cancer Type
6.3.2.2.4. By End user
6.3.3. Mexico Fiducial Markers Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Modality
6.3.3.2.3. By Cancer Type
6.3.3.2.4. By End user
7. Europe Fiducial Markers Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Modality
7.2.3. By Cancer Type
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Fiducial Markers Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Modality
7.3.1.2.3. By Cancer Type
7.3.1.2.4. By End user
7.3.2. France Fiducial Markers Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Modality
7.3.2.2.3. By Cancer Type
7.3.2.2.4. By End user
7.3.3. United Kingdom Fiducial Markers Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Modality
7.3.3.2.3. By Cancer Type
7.3.3.2.4. By End user
7.3.4. Italy Fiducial Markers Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Modality
7.3.4.2.3. By Cancer Type
7.3.4.2.4. By End user
7.3.5. Spain Fiducial Markers Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Modality
7.3.5.2.3. By Cancer Type
7.3.5.2.4. By End user
8. Asia Pacific Fiducial Markers Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Modality
8.2.3. By Cancer Type
8.2.4. By End user
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Fiducial Markers Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Modality
8.3.1.2.3. By Cancer Type
8.3.1.2.4. By End user
8.3.2. India Fiducial Markers Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Modality
8.3.2.2.3. By Cancer Type
8.3.2.2.4. By End user
8.3.3. Japan Fiducial Markers Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Modality
8.3.3.2.3. By Cancer Type
8.3.3.2.4. By End user
8.3.4. South Korea Fiducial Markers Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Modality
8.3.4.2.3. By Cancer Type
8.3.4.2.4. By End user
8.3.5. Australia Fiducial Markers Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Modality
8.3.5.2.3. By Cancer Type
8.3.5.2.4. By End user
9. Middle East & Africa Fiducial Markers Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Modality
9.2.3. By Cancer Type
9.2.4. By End user
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Fiducial Markers Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Modality
9.3.1.2.3. By Cancer Type
9.3.1.2.4. By End user
9.3.2. UAE Fiducial Markers Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Modality
9.3.2.2.3. By Cancer Type
9.3.2.2.4. By End user
9.3.3. South Africa Fiducial Markers Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Modality
9.3.3.2.3. By Cancer Type
9.3.3.2.4. By End user
10. South America Fiducial Markers Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Modality
10.2.3. By Cancer Type
10.2.4. By End user
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Fiducial Markers Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Modality
10.3.1.2.3. By Cancer Type
10.3.1.2.4. By End user
10.3.2. Colombia Fiducial Markers Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Modality
10.3.2.2.3. By Cancer Type
10.3.2.2.4. By End user
10.3.3. Argentina Fiducial Markers Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Modality
10.3.3.2.3. By Cancer Type
10.3.3.2.4. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Fiducial Markers Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. CIVCO Radiotherapy
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. IZI Medical Products
15.3. Boston Scientific Corporation
15.4. Naslund Medical AB
15.5. Best Medical International, Inc.
15.6. Nanovi A/S
15.7. Carbon Medical Technologies Inc.
15.8. Eckert & Ziegler
15.9. Innovative Oncology Solutions
15.10. Medtronic plc
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • CIVCO Radiotherapy
  • IZI Medical Products
  • Boston Scientific Corporation
  • Naslund Medical AB
  • Best Medical International, Inc.
  • Nanovi A/S
  • Carbon Medical Technologies Inc.
  • Eckert & Ziegler
  • Innovative Oncology Solutions
  • Medtronic plc

Table Information

Report AttributeDetails
No. of Pages187
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 97.38 Million
Forecasted Market Value ( USD ) by 2030 $ 132.75 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Fiducial Markers Market Report and Forecast 2025-2034 - Product Image

Fiducial Markers Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Fiducial Markers - Global Strategic Business Report - Product Image

Fiducial Markers - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Fiducial Marker Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Fiducial Marker Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Fiducial Markers Market - Global Forecast 2025-2032 - Product Image

Fiducial Markers Market - Global Forecast 2025-2032

  • Report
  • 185 Pages
  • Global
From
Thoracic Imaging The Requisites. Edition No. 3. Requisites in Radiology - Product Image

Thoracic Imaging The Requisites. Edition No. 3. Requisites in Radiology

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.